SMTSahajanand Medical Technologies Ltd.
Sahajanand Medical Technologies Q2 FY27 Results: Standalone Net Profit ₹9.83 Crore on Total Income of ₹161 Crore
- Earnings
- Medical devices
Reviewed byKeshav SehgalBlacklitt Research
Sahajanand Medical Technologies (NSE: SMT) reported standalone total income of ₹160.53 crore and net profit of ₹9.83 crore for the quarter ended 30 Sep 2026, it said in a filing on 05 Nov 2026. The filing covers standalone results only in the pages provided.
Key highlights
Standalone
The company on its own, without its subsidiaries
- Total income: ₹160.53 crore, up 17.4% YoY and 3.7% QoQ
- Net profit and EPS: ₹9.83 crore, down 19.5% YoY and up 5.5% QoQ; basic EPS ₹1.00
- Profit before tax: ₹13.05 crore, down 15.2% YoY and up 0.3% QoQ
- Finance costs: ₹4.23 crore, down 9.4% YoY
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 160.53 | 136.69 | +17.4% | 154.79 | +3.7% | |
| Revenue from operations | 158.58 | 134.96 | +17.5% | 153.39 | +3.4% |
| Other income | 1.95 | 1.73 | +12.7% | 1.40 | +38.8% |
| 9.83 | 12.21 | -19.5% | 9.32 | +5.5% | |
| Profit before tax | 13.05 | 15.38 | -15.2% | 13.02 | +0.3% |
| Finance costs | 4.23 | 4.67 | -9.4% | 4.16 | +1.8% |
| Depreciation | 5.07 | 5.08 | -0.1% | 4.74 | +6.9% |
| Tax expense | 3.22 | 3.18 | +1.4% | 3.70 | -12.9% |
| Net profit margin | 6.12% | 8.93% | -2.81 pp | 6.02% | +0.10 pp |
| EPS, basic (₹) | 1.00 | 1.26 | -20.6% | 0.95 | +5.3% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Net profit fell faster than income. Standalone total income rose 17.4% YoY to ₹160.53 crore, but net profit fell 19.5% to ₹9.83 crore, and profit before tax fell 15.2%. Revenue from operations, at ₹158.58 crore, rose 17.5%, so the gap is not explained by other income, which was ₹1.95 crore and 1.2% of total income.
Tax was a larger drag this quarter. Tax expense of ₹3.22 crore is 24.7% of profit before tax of ₹13.05 crore, against ₹3.18 crore on ₹15.38 crore a year earlier, a rate of about 20.7%. Depreciation of ₹5.07 crore was flat YoY and up 6.9% QoQ.
Other income of ₹1.95 crore is 14.9% of profit before tax, so the quarter's pre-tax profit rests mainly on operations. Finance costs of ₹4.23 crore are 2.6% of total income and fell 9.4% YoY.
The company's equity shares were listed on BSE and NSE on 23 Oct 2026 after an IPO of 1,38,22,116 shares at ₹344 each, an offer for sale by selling shareholders. The filing does not say whether the listing affects the quarter's figures. The consolidated quarterly profit and loss figures are not among the pages provided.
Inference
The filing states that the statement reviewed is the standalone one, and that the Board approved the Secretarial Auditor appointment for five years from FY 2026-27, subject to shareholder approval.
Blacklitt's data shows a consolidated Q2 FY27 net profit of ₹26.47 crore, but the consolidated quarter is not in the filing pages provided, so the filing does not show how the subsidiaries affect the standalone figures. What the consolidated quarter looks like is not known from this filing.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.